Speaker Detail

Ronald DePinho is president of the University of Texas MD Anderson Cancer Center. His research has focused on the molecular underpinnings of cancer, aging and degenerative disorders and the translation of such knowledge into clinical advances. DePinho's scientific career began at the Albert Einstein College of Medicine, where he was the Feinberg senior scholar in cancer research. He then joined the Department of Medical Oncology at the Dana-Farber Cancer Institute and the Harvard Medical School. At Harvard, he was the founding director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute and a professor of medicine and genetics. His honors and awards include the March of Dimes Basil O'Connor Award, the James S. McDonnell Scholar Award and the Cancer Research Institute Scholar Award. A member of the National Academy of Sciences, DePinho is a founder of Aveo Pharmaceuticals and a number of companies focused on cancer therapy and diagnostics. DePinho studied biology at Fordham University and received his M.D. from the Albert Einstein College of Medicine.